Target intelligence / Profile preview

Glucose production

Molecular classification
Other
01

Overview

Glucose production is not a single molecule or receptor but rather a physiological process primarily involving the liver and kidneys. It refers to the generation of new glucose molecules through two main metabolic pathways: glycogenolysis (breakdown of stored glycogen) and gluconeogenesis (synthesis of new glucose from non-carbohydrate precursors such as lactate, amino acids, and glycerol)[3][5]. These processes are tightly regulated by hormones including insulin and glucagon. During fasting or starvation, endogenous glucose production is essential for maintaining blood sugar levels—especially for tissues like the brain that rely heavily on glucose as an energy source[4][8]. Dysregulation leads to diseases such as diabetes mellitus. While drugs like metformin target this process therapeutically by inhibiting hepatic gluconeogenesis in type 2 diabetes[5], "glucose production" itself is not a discrete molecular target but rather an aggregate function resulting from multiple enzymatic activities. Summary: "Glucose production" does not correspond to a specific molecule or receptor; it describes a complex physiological process involving many enzymes and regulatory factors. Therefore, it should not be considered a canonical therapeutic target entity but rather an important metabolic function relevant to disease states such as diabetes mellitus[3][5].

Other names
hepatic glucose productionendogenous glucose production
02

Mechanism of action

Inhibition of gluconeogenesis enzymes (e.g., metformin inhibits hepatic gluconeogenesis)[5]

03

Biological functions

Glucose homeostasisEnergy metabolismResponse to fasting and feeding statesMaintenance of blood glucose levels
04

Disease associations

Diabetes mellitus (especially type 2 diabetes)HypoglycemiaMetabolic syndromeObesity (indirectly, via insulin resistance)
05

Safety considerations

Risk of hypoglycemia with excessive suppression in diabetes therapy[3]Lactic acidosis risk with metformin use in renal impairment[5]
06

Interacting drugs

Metformin

2 more in the full profile.

07

Biomarkers

Fasting plasma glucoseHbA1c (glycated hemoglobin)

Beyond the preview

Go deeper on Glucose production.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose production.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call